Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44021745HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44014146HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44000462HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021746HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44033264HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44037432HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB12278
Drug NamePropiverine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs16406943
CitationsMaruyama S, Oki T, Otsuka A, Shinbo H, Ozono S, Kageyama S, Mikami Y, Araki I, Takeda M, Masuyama K, Yamada S: Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol. 2006 Jan;175(1):365-9.
GroupsApproved; Investigational
Direct ClassificationDiphenylmethanes
SMILESCCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL1078261